Company / Income Tax per Share
ALNYLAM PHARMACEUTICALS, INC. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.07
FY2025
5-year range
-$0.79 / $0.07
FY2021-FY2025
Trend
+109.2%
vs FY2024
Sector context
#48 of 201
Health Care
What the data says
ALNYLAM PHARMACEUTICALS, INC.'s income tax per share of $0.07 is higher than 76% of companies in the Health Care sector (FY2025). Increased from $0.05 to $0.07 over the past 2 years.
Based on SEC 10-K filings.
0.07 in FY2025 with a 5-year CAGR of +58.2%. Top quartile in the Health Care sector.
Increased from $0.05 to $0.07 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +48.3%
- 5-Year CAGR
- +58.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 201This company $0.07 Sector average $1.35
▼
-94.6% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 109.2% year-over-year.
- Ranks #48 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.37 (distress zone, below 1.8 threshold)
- Negative profit margin: -12.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | +109.2% |
| FY2024 | -$0.79 | -1553.4% |
| FY2023 | $0.05 | +143.3% |
| FY2022 | $0.02 | +201.0% |
| FY2021 | $0.01 | +1.0% |
| FY2020 | $0.01 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026